IZAFE B Stock Overview
A life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
iZafe Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.24 |
| 52 Week High | SEK 0.30 |
| 52 Week Low | SEK 0.17 |
| Beta | 0.44 |
| 1 Month Change | 5.31% |
| 3 Month Change | 9.17% |
| 1 Year Change | -15.30% |
| 3 Year Change | -69.84% |
| 5 Year Change | -91.27% |
| Change since IPO | -96.34% |
Recent News & Updates
Shareholder Returns
| IZAFE B | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | 0.8% | 3.1% | 1.8% |
| 1Y | -15.3% | 38.0% | 15.2% |
Return vs Industry: IZAFE B underperformed the Swedish Healthcare Services industry which returned 39.7% over the past year.
Return vs Market: IZAFE B underperformed the Swedish Market which returned 14% over the past year.
Price Volatility
| IZAFE B volatility | |
|---|---|
| IZAFE B Average Weekly Movement | 10.1% |
| Healthcare Services Industry Average Movement | 6.7% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 12.3% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: IZAFE B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: IZAFE B's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 7 | Anders Segerstrom | www.izafe.se |
iZafe Group AB (publ), a life-science company, engages in the research, development, and marketing of digital medical solutions and services for safer drug management at home. The company provides Dosell, an automated drug dispenser that handles dose bags, facilitates and enables independent medication, and reminds and alerts if the current dose is not taken at the right time. It serves consumers, and public and private-sector care providers in Sweden, the Nordic region, and internationally.
iZafe Group AB (publ) Fundamentals Summary
| IZAFE B fundamental statistics | |
|---|---|
| Market cap | SEK 65.59m |
| Earnings (TTM) | -SEK 31.99m |
| Revenue (TTM) | SEK 6.29m |
10.4x
P/S Ratio-2.1x
P/E RatioIs IZAFE B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IZAFE B income statement (TTM) | |
|---|---|
| Revenue | SEK 6.29m |
| Cost of Revenue | SEK 6.38m |
| Gross Profit | -SEK 95.00k |
| Other Expenses | SEK 31.89m |
| Earnings | -SEK 31.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | -0.12 |
| Gross Margin | -1.51% |
| Net Profit Margin | -508.73% |
| Debt/Equity Ratio | 37.5% |
How did IZAFE B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 04:42 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
iZafe Group AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jesper Birch-Jensen | ABG Sundal Collier Sponsored |